Bli medlem
Bli medlem

Du är här

Analysguiden, intervju med Redwood Pharmas vd Martin Vidaeus

 

Interview with CEO Martin Vidaeus. We talk about the new focus on RP501 for dry eye disease, approachable market and the next phase for the program.